# Bioavailability Study Comparing 2 Vamifeport Oral Formulations in Fasted Versus Fed State in Healthy Subjects

> **NCT05077436** · PHASE1 · COMPLETED · sponsor: **Vifor (International) Inc.** · enrollment: 28 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Vamifeport Formulation 1
- **DRUG:** Vamifeport Formulation 2

## Key facts

- **NCT ID:** NCT05077436
- **Lead sponsor:** Vifor (International) Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-14
- **Primary completion:** 2021-12-29
- **Final completion:** 2022-01-05
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2022-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05077436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05077436, "Bioavailability Study Comparing 2 Vamifeport Oral Formulations in Fasted Versus Fed State in Healthy Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05077436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*